Showing:
◈ medical devices×
The Nuffield Trust think tank has published a new report on the impact of Brexit on the UK’s health and care services. The ongoing monitoring work, funded by the Health Foundation, covers the impact on the NHS and social care workforce, medicine and medical devices supply and the economic cost, and reveals negative effects across these areas.
The impact of Brexit has only added fuel to the fire of severe challenges facing health and social care in the UK, warns the Nuffield Trust.
The NHS and Brexit: What We Now Know
05/01/2023
Sam Bright examines the contribution of Brexit to our current healthcare crisis.
THE SEISMIC CHANGES to the relationship with our nearest neighbours and the impact of Brexit have only added fuel to the fire of severe challenges facing health and social care in the UK today, making people less healthy and widening health inequalities.
Brexit shut off the “relief valve” of immigration from the European Union, worsening workforce shortages in health and social care in the UK, a report from the Nuffield Trust think tank has concluded. / Brexit’s effect has been felt particularly in specialties such as cardiothoracic surgery and anaesthesia, and in dentistry and the care sector.
Are you a quality manager for a small medical device start-up looking to expand into global markets? Or maybe you are a seasoned device manufacturer preparing to once again traverse quality regulations to deliver a new product to the European market?
The Medicines and Healthcare products Regulatory Agency (MHRA) has appointed its first certification body since the UK left the EU
03/10/2022
With the exception of the very lowest risk devices, manufacturers must apply to a UK approved body. Only after they have UKCA certification can their products be placed on the market in England, Wales and Scotland.
The Brexit predictions that came true, those that didn’t—and what we didn’t see coming - BMJ
03/08/2022
Six years after the referendum we can disentangle the evidence and judge the effects on health and care, says Richard Vize.
Brexit comes with uncertainty regarding the approval of medicines and medical devices, including software and technology. Regulatory hurdles could disrupt the approval of existing and new devices and technology.
For new medical devices entering the UK market, they will only need to comply with the old, and for some, less stringent, device standard (MDR, 2002). / ... Coupled with the additional authorisation process required to reach the UK market, this may lead to delays or deter companies from selling their products in the UK altogether.
From 1 January 2021, the medical device regulatory landscape in the UK changed. The regulatory structure for medical devices is very complicated and fragmented. / Listed below are the old and new medical device regulations in EU and the UK, as identified by GlobalData.
Medical devices illustrate the limited scope for post-Brexit UK divergence from EU rules, and the trade-offs the UK must face. / 'Many manufacturers have suggested they will not bother with the additional cost and complexity of putting their devices through the UKCA processes on top of the updated European process.'
Following the UK’s exit from the EU, the regulatory landscape for medical devices remains uncertain. Andrew Thompson, PhD, director of therapy research & analysis at GlobalData, explains what companies need to know.
Post-Brexit issues for the NHS
19/01/2022
There are a number of measures that the UK Government must take in order to address the challenges of leaving the EU's single market.
Nuffield Trust: Slow decisions and vague trade slogans leave NHS uncertain of post-Brexit future
20/12/2021
Our report published today looks at six key areas of health and social care that are being impacted by Brexit.
There are supply issues with medical devices, fuel and food costs.
UK drug distributors and those involved in the parallel importing of drugs have told the parliamentary Health Select Committee that they want to see the UK remain in the customs union and the single market.
The prime minister has imperilled peace in Northern Ireland, and every day the economic fallout worsens.
Brexit disruption to medicine supply lines would be unacceptable, Health Minister Robin Swann says
22/04/2021
Health Minister Robin Swann has voiced concern about the supply line of medicines to Northern Ireland as a result of a looming Brexit regulatory barrier.
NI Brexit: Supply of medicines to NI fears as end of grace period looms - Health Minister Robin Swann admits he is concerned
22/04/2021
Northern Ireland’s Health Minister Robin Swann has voiced concern about the supply of medicines to the region as a result of a looming Brexit regulatory barrier to securing stock from the rest of the UK.
The chief pharmaceutical officer has warned that without mitigation, the supply of medicines and medical devices into Northern Ireland would be considered a "very high risk area".
The UK should implement new EU medical device regulation into legislation post Brexit transition - Poll
29/03/2021
The new European Union (EU) Medical Devices Regulation (MDR) and In Vitro Diagnostic Medical Devices Regulation (IVDR) are due to be implemented across the EU from May 2021.
Medical devices in the UK will lack adequate safety standards until new post-Brexit regulations come into effect: Poll
22/03/2021
Verdict has conducted a poll to analyse whether medical devices in the UK will continue to have a high degree of safety until all new post-Brexit regulations come into effect by 2023.
For almost 50 years, the NHS benefited from easy access to a large market, meaning it’s been first in the queue for the latest innovations. But what impact might Brexit have on medicines, medical devices and life sciences in the UK? Mark Dayan explains, in a blog that was first published in the BMJ on 26 February.